Suspension of trading
Valuation Aceso Life Science Group Limited
Stocks
474
KYG0070S1066
Heavy Machinery & Vehicles
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1140 HKD | -.--% |
|
-.--% | +1.79% |
| 05-05 | Aceso Life Subscribes for HK$167.3 Million of Imagi Fin Shares | MT |
| 05-04 | Aceso Life Science to subscribe for Imagi Fin Group shares for HK$167.32 million | RE |
Company Valuation: Aceso Life Science Group Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,224 | 1,574 | 472.4 | 1,314 | 1,174 | 369.1 |
| Change | - | 28.51% | -69.98% | 178.13% | -10.67% | -68.55% |
| Enterprise Value (EV) 1 | 3,011 | 3,660 | 2,765 | 3,634 | 3,443 | 2,458 |
| Change | - | 21.55% | -24.43% | 31.41% | -5.26% | -28.6% |
| P/E | -4.09x | -3.59x | -1.15x | -4.93x | -2.5x | -0.4x |
| PBR | 0.49x | 0.66x | 0.24x | 0.85x | 1.27x | 30.8x |
| PEG | - | -0.1x | 0.1x | 0.1x | -0x | -0x |
| Capitalization / Revenue | -7.73x | 16.1x | 2.78x | 6.35x | 107x | -5.2x |
| EV / Revenue | -19x | 37.3x | 16.3x | 17.6x | 313x | -34.6x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0491 | -0.0633 | -0.0555 | -0.0361 | -0.0635 | -0.1244 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | -158.5 | 98 | 170 | 207 | 11 | -71 |
| EBITDA | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - |
| Net income 1 | -283.7 | -376 | -370 | -264 | -462 | -895 |
| Net Debt 1 | 1,786 | 2,086 | 2,293 | 2,320 | 2,269 | 2,089 |
| Reference price 2 | 0.2010 | 0.2270 | 0.0640 | 0.1780 | 0.1590 | 0.0500 |
| Nbr of stocks (in thousands) | 6,091,887 | 6,931,887 | 7,381,777 | 7,381,777 | 7,381,777 | 7,381,777 |
| Announcement Date | 7/29/20 | 7/22/21 | 7/28/22 | 7/26/23 | 7/26/24 | 7/30/25 |
1HKD in Million2HKD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 129M | |
| 32.03x | 3.12x | 15.78x | - | 12.99B | |
| 19.24x | 2.06x | 10.54x | 1.44% | 12.52B | |
| 21.5x | 1.33x | 10.98x | 1.29% | 9.16B | |
| -12.16x | - | - | - | 408M | |
| 52.55x | 0.21x | 4.16x | - | 92.48M | |
| Average | 22.63x | 1.68x | 10.36x | 1.36% | 5.88B | |
| Weighted average by Cap. | 24.28x | 2.26x | 12.60x | 1.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 474 Stock
- Valuation Aceso Life Science Group Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
